Response to 'Kidney disease in moderate-to-severe psoriasis: a critical appraisal'.
作者信息
Wan J, Gelfand J M
机构信息
Department of Dermatology and the Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, U.S.A.
出版信息
Br J Dermatol. 2016 Feb;174(2):270-1. doi: 10.1111/bjd.14304.
Abstract
摘要
相似文献
1
Response to 'Kidney disease in moderate-to-severe psoriasis: a critical appraisal'.
Br J Dermatol. 2016 Feb;174(2):270-1. doi: 10.1111/bjd.14304.
2
Kidney disease in moderate-to-severe psoriasis: commentary.
Br J Dermatol. 2016 Feb;174(2):271-2. doi: 10.1111/bjd.14303.
3
Chronic kidney disease: Psoriasis--a risk factor for chronic kidney disease?
Nat Rev Nephrol. 2014 Jan;10(1):12-3. doi: 10.1038/nrneph.2013.254. Epub 2013 Nov 26.
4
Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis.
Int Urol Nephrol. 2018 Jul;50(7):1277-1283. doi: 10.1007/s11255-018-1868-z. Epub 2018 Apr 11.
5
Psoriasis and chronic kidney disease among the United States adult population.
J Am Acad Dermatol. 2023 Oct;89(4):834-837. doi: 10.1016/j.jaad.2023.06.011. Epub 2023 Jun 13.
6
Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study.
Br J Dermatol. 2015 Jul;173(1):146-54. doi: 10.1111/bjd.13599. Epub 2015 May 12.
7
Psoriasis and the life cycle of persistent life effects.
Dermatol Clin. 2015 Jan;33(1):25-39. doi: 10.1016/j.det.2014.09.003.
8
9
The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
Int J Cardiol. 2007 Apr 12;117(1):64-74. doi: 10.1016/j.ijcard.2006.06.003. Epub 2006 Aug 4.
10
No Relation between Psoriasis and Renal Abnormalities: A Case-Control Study.
ScientificWorldJournal. 2018 Feb 11;2018:5301631. doi: 10.1155/2018/5301631. eCollection 2018.
本文引用的文献
1
Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: A nationwide population-based cohort study.
J Dermatol Sci. 2015 Jun;78(3):232-8. doi: 10.1016/j.jdermsci.2015.03.012. Epub 2015 Mar 30.
2
Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study.
Acta Derm Venereol. 2015 Sep;95(7):809-15. doi: 10.2340/00015555-2095.
3
Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study.
Br J Dermatol. 2015 Jul;173(1):146-54. doi: 10.1111/bjd.13599. Epub 2015 May 12.
4
Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom.
JAMA Dermatol. 2015 Feb;151(2):161-9. doi: 10.1001/jamadermatol.2014.2094.
5
Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study.
BMJ. 2013 Oct 15;347:f5961. doi: 10.1136/bmj.f5961.
6
Validity of The Health Improvement Network (THIN) for the study of psoriasis.
Br J Dermatol. 2011 Mar;164(3):602-9. doi: 10.1111/j.1365-2133.2010.10134.x. Epub 2011 Feb 3.
7
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.
Br J Dermatol. 2009 Nov;161(5):987-1019. doi: 10.1111/j.1365-2133.2009.09505.x.
8
British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005.
Br J Dermatol. 2005 Sep;153(3):486-97. doi: 10.1111/j.1365-2133.2005.06893.x.
9
Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease.
Br J Dermatol. 1996 Oct;135(4):533-7.
Zotero 插件